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Reversible activation of pH-sensitive cell
penetrating peptides attached to gold surfaces†
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Christoph Bubeck,a Katharina Landfester,a Mischa Bonn,a Michael Bruns,b
Clemens K. Weissac and Tobias Weidner*a
pH-sensitive viral fusion proteinmimics arewidely touted as a promising
route towards site-specific delivery of therapeutic compounds across
lipid membranes. Here, we demonstrate that a fusion protein mimic,
designed to achieve a reversible, pH-driven helix-coil transition mecha-
nism, retains its functionality when covalently bound to a surface.
The controlled and selective delivery of therapeutic compounds
into cells is a key element of targeted drug delivery therapies.
Promising targeting mechanisms include drug loaded nano-
particles (NPs). The surface functionalities of NPs can be designed
to control particle uptake in cells.1–11 Therefore, to target specific
cell types or tissues, targeting ligands, such as folic acid,12–15
carbohydrates,16,17 peptides or proteins14,18–21 can be attached to
a particle’s surface.6,22,23 However, one hurdle that has impeded the
widespread deployment of drug loaded NPs is the fact that certain
drugs are only active within a cell’s cytosol. Following cellular
uptake, NPs are usually trapped in endosomes,5 unable to reach
their therapeutic targets. To reach the cytosol, NPs need the ability
to penetrate through the endosomal membrane barrier while
ideally leaving the cell plasma membrane intact.
Viruses face these same challenges when delivering their genes
from endosomes into the cytosol and have devised specialized
fusion proteins that promote endosomal escape.24 The activity of
these proteins is triggered by a structural transition induced by the
low pH in endosomes (pH B 5); this transition is reversed within
the cell cytosol (pHB 7), de-activating the protein. Artificial peptide
mimics of these pH-sensitive viral fusion proteins therefore, repre-
sent a promising route to achieve site-specific membrane
interactions.1–4,25–29 A member of the family of pH-sensitive pep-
tides, GALA (WEAALAEAL-AEALAEHLAEALAEALEALAA), has
attracted particular attention as a potential candidate for effective
and specific permeation.2 GALA’s secondary structure depends on
the pHof the local environment. In physiologically low pHs, i.e. pH=
5, GALA forms a stable a-helical secondary structure. Due to the
hydrophobic/hydrophilic surfaces in this state, GALA is likely to
assemble into bundles of helices, causing pore formation and
membrane leakage. At basic pH, the glutamic acid side chains are
deprotonated and, as a result, charged, causing the helix to destabi-
lize. In this high-pH state GALA is no longer membrane active.26
GALA has been shown to eﬀectively penetrate and permeate
cell lipid bilayers and enhance the endosomal escape following
internalization of drug-loaded vesicles via endocytosis, and, thus,
the drug delivery eﬃciency.26,30 However, the application of GALA
bound to surfaces has not been reported so far. For targeted drug
delivery and the design of ‘smart’ biological surfaces, the peptide
needs to be immobilized onto a substrate. The secondary struc-
ture can be strongly aﬀected by charge and hydrophobicity of
surfaces and the confinement in the high peptide concentration
near the surface may interfere with pH-controlled folding
and unfolding and might alter the pK-value.31–33 Therefore, the
challenge with the functionality of solid-supported proteins and
self-assembled monolayers (SAM) of peptides is understanding
the interaction between the protein and surface.
A barrier for the rational design of eﬃcient and reliable drug
delivery vehicles by bioengineers and chemists is our current lack
of understanding of structural properties of such pH sensitive
peptide-SAMs on amolecular level. Surface sensitive spectroscopies
have recently been used to determine folding and orientation of a
range of peptides covalently attached to surfaces for applications in
catalysis,34 biomaterials35 and antimicrobial surfaces.36 Progress in
the field has also been summarized in recent reviews about peptide
SAMs.37,38 In this work, we approximate the conditions of a
GALA-SAM bound to gold NPs by specific binding of GALA onto
gold surfaces via a cysteine residue we have synthetically added
at the C-terminus of the GALA sequence (GALA-Cys: WEAALAEA
LAEALAEHLAEALAEALEALAA-C). Cysteine side chains can reliably
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link peptides or proteins to gold.39 The covalent thiol–gold bond
induces ordered adsorption and can lead to well-aligned protein
films.39–42 We verified that the addition of a cysteine residue does
not interfere with the pH-driven refolding by infrared spectra of
GALA-Cys dissolved in bulk D2O (ESI†). A schematic of the GALA-Au
binding scheme is shown in Fig. 1. The formation of a closed,
well-defined protein monolayer is crucial, therefore, quantitative
characterization of the composition and chemical integrity of
GALA-Cys films on Au were provided by X-ray photoelectron
spectroscopy (XPS), surface plasmon resonance (SPR), electro-
chemical impedance spectroscopy (EIS), surface-enhanced infrared
absorption spectroscopy (SEIRAS) and atomic force microscopy
(AFM). Resistance and capacitance values collected across the
GALA-Cys film by EIS indicate a homogenous film which is also
supportedbyatomic forcemicroscopy (AFM) imagesrecordedbefore
and after the SAM-formation that illustrate the lack of aggregates,
particles or domains at the surface (see ESI†). The XPS determined
film compositions are in agreement with the theoretical composi-
tion of a GALA-cysmonolayer on Au (see ESI†). The thickness of this
adsorbed protein layer, determined by SEIRAS and SPR angle scans
taken before and after monolayer formation, yields a peptide layer
thickness of 1.5 nm  0.5 nm (see ESI†). This thickness value
indicates an inclined adsorption geometry. The tilt angle of the
peptidehelix canbe estimated tobeB201with respect to the surface
assuming a peptide length ofB5 nm. At a 201 angle, aGALApeptide
occupies an area of about 450 Å2, compared with a footprint of
B100 Å2 expected for a fully upright orientation. Combined, the
surface analytical techniques illustrated a well packed and strongly
inclined monolayer of GALA-Cys bound covalently to the gold
surface.
To determine if the secondary structure of GALA remains
pH-sensitive after surface attachment we probed a monolayer
of the GALA-Cys peptides adsorbed onto a gold film with sum
frequency generation (SFG) vibrational spectroscopy. Like other
vibrational spectroscopic techniques, amide modes observed
within SFG spectra can be used to identify secondary structures.
However, SFG selection rules dictate that an SFG response
will only originate from a surface or interface where inversion
symmetry is broken. As a result of these selection rules – we expect
that any vibrational mode observed within the amide I stretching
region will only originate from ordered, non-antiparallel or non-
random secondary structures immobilized at the Au substrate.
GALA-Cys was self-assembled on a 7 nm gold island film
evaporated onto a CaF2 prism (Fig. 2, upper scheme). SFG spectra
in the amide I region of the vibrational spectrum (1550–1750 cm1)
were collected at four consecutive different buffer pH values (pH = 5,
9, 12 and 3) (Fig. 2, lower scheme). At pH = 5, the spectrum contains
a vibrational mode at 1650 cm1 which is characteristic of ordered
a-helices, and two weaker bands at 1630 and 1675 cm1 related to
ordered b-sheets. As the pH was increased to 9 and then to 12 the
magnitude of the 1650 cm1 peak is dramatically reduced, while the
two other modes related to b-sheets are small but remain. Random
and unordered secondary structure may also exist at this pH but are
not detected by SFG. As the pH of the buffer solution is lowered
down to pH 3, the peak at 1650 cm1 reappears, consistent with the
notion that the pH triggered, reversible conformational change into
a-helices is retained when GALA is immobilized on surfaces. To
test whether surface-bound GALA can disrupt lipid bilayers in a
similar way as free GALA in solution, a fluorescence imaging assay
was performed (Fig. 3). In analogy to leakage studies in solution,
rhodamine-B labeleddipalmitoylphosphatidylcholine (DPPC)vesicles
where deposited onto a GALA-Cys SAM in the presence of sodium
dithionite (DTT) solution. Dyemolecules attached to the outer leaflet
were oxidized and quenched by DDT – rhodamine attached to the
inner leaflet was protected by the vesicle membrane. Fig. 3a and b
show fluorescence images recorded at pH 9 and pH 5. At high pH the
fluorescence of intact individual and clustered vesicles are clearly
visible. At pH5 the fluorescence yield is greatly reduced by quenching
of rhodamine at the inner leaflet due tomembrane leakage causedby
active GALA peptides.
Whiledetailedcell studiesareneeded to investigate the impact, for
example, of GALA on particle uptake and endosomal escape under
physiological conditions, this investigation takes an important first
Fig. 1 Immobilization scheme of cysteine-terminated GALA peptides on
gold surfaces.
Fig. 2 Upper scheme: experimental SFG setup. Lower scheme: SFG
spectra of GALA adsorbed on Au (black) measured under acidic, basic,
and again acidic conditions. The spectra were taken under PPP-
polarization conditions and Lorentzian band shapes were fitted to the
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step. The results illustrate that the controlled confinement of
viral fusion peptide mimics to a gold surface does not interfere
with the controlled folding and membrane activity of the GALA
sequence. We have demonstrated that a GALA-Cys SAM can be
self-assembled onto Au-surfaces by inserting a single cysteine to
the peptide terminus. Both the addition of a single Cys and
chemical adsorption onto a solid substrate does not alter the pH-
driven structural transition of GALA or its activity – indicating
that the attachment of GALA to surfaces is a viable approach to
functionalizing particles surfaces with pH responsive peptide
coatings.
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Fig. 3 Vesicle escape study on GALA-Cys SAMs. The fluorescence of
DPPC vesicles carrying rhodamine B-labels is quenched by DTT if active
GALA at pH 5 permeates the lipid bilayer. Image (a): fluorescence image of
GALA SAM decorated with rhodamine-labeled vesicles at pH 9. Image (b):
at pH 5 the fluorescence is significantly reduced by the release of
rhodamine from disintegrated vesicles and subsequent interaction with
quencher in the bulk. The scale bars represent 50 mm.
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